Biotech

All Articles

Praxis epilepsy medicine decreases seizures in period 2 trial

.Praxis Accuracy Medicines has actually racked up yet another midphase succeed in epilepsy this year...

Three officers resign as Dyne blog posts combined records for DMD candidate

.After running away a medical grip several years back, Dyne Therapeutics has uncovered brand-new per...

Arrowhead fires off period 3 records in uncommon metabolic illness in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its hand ahead of a potential face-off along with I...

Pfizer, Valneva present lyme disease try efficient for second booster

.Pfizer and also Valneva may have concerning pair of more years to wait just before they create the ...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a chat with Ayla Ellison, Intense Biotech Editor-in-Chief and Michelle Benz as th...

New records show how Bayer's asundexian fell short to prevent movements

.Bayer suspended the phase 3 trial for its element XIa prevention asundexian behind time last year a...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its own multiple sclerosis (MS) med tolebrutinib to the F...

Galapagos' stock up as fund reveals intent to shape its development

.Galapagos is coming under extra tension coming from investors. Having actually built a 9.9% risk in...

Cell- concentrated Sana scoops initial CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings...

Allist settles Jacobio $21M, landing task in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has purchased itself a starring role in China's KRAS market, paying...